MDMA Submits Comments to FDA Transparency Task Force

MDMA submitted comments to the FDA Transparency Task Force, a group created by the FDA to improve transparency at the Agency. MDMA used the opportunity to highlight some of the industry's transparency concerns associated with the panel process for device reviews.